• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of postmedjPostgraduate Medical JournalVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
Postgrad Med J. Aug 2005; 81(958): 486–490.
PMCID: PMC1743339

Diabetes and ethnic minorities

Full Text

The Full Text of this article is available as a PDF (81K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Wild Sarah, Roglic Gojka, Green Anders, Sicree Richard, King Hilary. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004 May;27(5):1047–1053. [PubMed]
  • Rangasami JJ, Greenwood DC, McSporran B, Smail PJ, Patterson CC, Waugh NR. Rising incidence of type 1 diabetes in Scottish children, 1984-93. The Scottish Study Group for the Care of Young Diabetics. Arch Dis Child. 1997 Sep;77(3):210–213. [PMC free article] [PubMed]
  • Glaser NS. Non-insulin-dependent diabetes mellitus in childhood and adolescence. Pediatr Clin North Am. 1997 Apr;44(2):307–337. [PubMed]
  • Li XH, Li TL, Yang Z, Liu ZY, Wei YD, Jin SX, Hong C, Qin RL, Li YQ, Dorman JS, et al. A nine-year prospective study on the incidence of childhood type 1 diabetes mellitus in China. Biomed Environ Sci. 2000 Dec;13(4):263–270. [PubMed]
  • Elamin A, Omer MI, Zein K, Tuvemo T. Epidemiology of childhood type I diabetes in Sudan, 1987-1990. Diabetes Care. 1992 Nov;15(11):1556–1559. [PubMed]
  • Baker JR., Jr Autoimmune endocrine disease. JAMA. 1997 Dec 10;278(22):1931–1937. [PubMed]
  • Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med. 1997;14 (Suppl 5):S1–85. [PubMed]
  • Riste L, Khan F, Cruickshank K. High prevalence of type 2 diabetes in all ethnic groups, including Europeans, in a British inner city: relative poverty, history, inactivity, or 21st century Europe? Diabetes Care. 2001 Aug;24(8):1377–1383. [PubMed]
  • Singh R, Shaw J, Zimmet P. Epidemiology of childhood type 2 diabetes in the developing world. Pediatr Diabetes. 2004 Sep;5(3):154–168. [PubMed]
  • Wiegand Susanna, Maikowski Ursula, Blankenstein Oliver, Biebermann Heike, Tarnow Patrick, Grüters Annette. Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity -- a problem that is no longer restricted to minority groups. Eur J Endocrinol. 2004 Aug;151(2):199–206. [PubMed]
  • Story Mary, Stevens June, Himes John, Stone Elaine, Rock Bonnie Holy, Ethelbah Becky, Davis Sally. Obesity in American-Indian children: prevalence, consequences, and prevention. Prev Med. 2003 Dec;37(6 Pt 2):S3–12. [PubMed]
  • Ehtisham S, Hattersley AT, Dunger DB, Barrett TG. First UK survey of paediatric type 2 diabetes and MODY. Arch Dis Child. 2004 Jun;89(6):526–529. [PMC free article] [PubMed]
  • Stride Amanda, Hattersley Andrew T. Different genes, different diabetes: lessons from maturity-onset diabetes of the young. Ann Med. 2002;34(3):207–216. [PubMed]
  • Bhopal R, Unwin N, White M, Yallop J, Walker L, Alberti KG, Harland J, Patel S, Ahmad N, Turner C, et al. Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study. BMJ. 1999 Jul 24;319(7204):215–220. [PMC free article] [PubMed]
  • Simmons D, Williams DR, Powell MJ. Prevalence of diabetes in different regional and religious south Asian communities in Coventry. Diabet Med. 1992 Jun;9(5):428–431. [PubMed]
  • Abraham R, Brown MC, North WR, McFadyen IR. Diets of Asian pregnant women in Harrow: iron and vitamins. Hum Nutr Appl Nutr. 1987 Jun;41(3):164–173. [PubMed]
  • Hayes Louise, White Martin, Unwin Nigel, Bhopal Raj, Fischbacher Colin, Harland Jane, Alberti KGMM. Patterns of physical activity and relationship with risk markers for cardiovascular disease and diabetes in Indian, Pakistani, Bangladeshi and European adults in a UK population. J Public Health Med. 2002 Sep;24(3):170–178. [PubMed]
  • Whincup Peter H, Gilg Julie A, Papacosta Olia, Seymour Carol, Miller George J, Alberti KGMM, Cook Derek G. Early evidence of ethnic differences in cardiovascular risk: cross sectional comparison of British South Asian and white children. BMJ. 2002 Mar 16;324(7338):635–635. [PMC free article] [PubMed]
  • Eriksson JG, Forsén T, Tuomilehto J, Jaddoe VWV, Osmond C, Barker DJP. Effects of size at birth and childhood growth on the insulin resistance syndrome in elderly individuals. Diabetologia. 2002 Mar;45(3):342–348. [PubMed]
  • Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia. 1993 Jan;36(1):62–67. [PubMed]
  • Fuller KE. Low birth-weight infants: the continuing ethnic disparity and the interaction of biology and environment. Ethn Dis. 2000 Autumn;10(3):432–445. [PubMed]
  • Gopalan C. Current food and nutrition situation in south Asian and south-east Asian countries. Biomed Environ Sci. 1996 Sep;9(2-3):102–116. [PubMed]
  • Yajnik CS, Lubree HG, Rege SS, Naik SS, Deshpande JA, Deshpande SS, Joglekar CV, Yudkin JS. Adiposity and hyperinsulinemia in Indians are present at birth. J Clin Endocrinol Metab. 2002 Dec;87(12):5575–5580. [PubMed]
  • Must A, Strauss RS. Risks and consequences of childhood and adolescent obesity. Int J Obes Relat Metab Disord. 1999 Mar;23 (Suppl 2):S2–11. [PubMed]
  • Lönnqvist F, Thörne A, Large V, Arner P. Sex differences in visceral fat lipolysis and metabolic complications of obesity. Arterioscler Thromb Vasc Biol. 1997 Jul;17(7):1472–1480. [PubMed]
  • Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care. 1994 Sep;17(9):961–969. [PubMed]
  • Shaper AG, Wannamethee SG, Walker M. Body weight: implications for the prevention of coronary heart disease, stroke, and diabetes mellitus in a cohort study of middle aged men. BMJ. 1997 May 3;314(7090):1311–1317. [PMC free article] [PubMed]
  • Colditz GA, Willett WC, Stampfer MJ, Manson JE, Hennekens CH, Arky RA, Speizer FE. Weight as a risk factor for clinical diabetes in women. Am J Epidemiol. 1990 Sep;132(3):501–513. [PubMed]
  • Nakagami T, Qiao Q, Carstensen B, Nhr-Hansen C, Hu G, Tuomilehto J, Balkau B, Borch-Johnsen K. Age, body mass index and Type 2 diabetes-associations modified by ethnicity. Diabetologia. 2003 Aug;46(8):1063–1070. [PubMed]
  • Luke A, Durazo-Arvizu R, Rotimi C, Prewitt TE, Forrester T, Wilks R, Ogunbiyi OJ, Schoeller DA, McGee D, Cooper RS. Relation between body mass index and body fat in black population samples from Nigeria, Jamaica, and the United States. Am J Epidemiol. 1997 Apr 1;145(7):620–628. [PubMed]
  • Ramirez LC, Arauz-Pacheco C, Lackner C, Albright G, Adams BV, Raskin P. Lipoprotein (a) levels in diabetes mellitus: relationship to metabolic control. Ann Intern Med. 1992 Jul 1;117(1):42–47. [PubMed]
  • Bennion LJ, Grundy SM. Effects of diabetes mellitus on cholesterol metabolism in man. N Engl J Med. 1977 Jun 16;296(24):1365–1371. [PubMed]
  • Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H. Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6434–6438. [PMC free article] [PubMed]
  • Harris Stewart B, Zinman Bernard, Hanley Anthony, Gittelsohn Joel, Hegele Robert, Connelly Phillip W, Shah Baiju, Hux Janet E. The impact of diabetes on cardiovascular risk factors and outcomes in a native Canadian population. Diabetes Res Clin Pract. 2002 Feb;55(2):165–173. [PubMed]
  • Collins R, Peto R, Godwin J, MacMahon S. Blood pressure and coronary heart disease. Lancet. 1990 Aug 11;336(8711):370–371. [PubMed]
  • Saunders E. Hypertension in blacks. Med Clin North Am. 1987 Sep;71(5):1013–1029. [PubMed]
  • Li Suying, McAlpine Donna D, Liu Jiannong, Li Shuling, Collins Allan J. Differences between blacks and whites in the incidence of end-stage renal disease and associated risk factors. Adv Ren Replace Ther. 2004 Jan;11(1):5–13. [PubMed]
  • Corry D, Tuck M. Hypertension and diabetes. Semin Nephrol. 1991 Sep;11(5):561–570. [PubMed]
  • Gibson T, Waterworth R, Hatfield P, Robinson G, Bremner K. Hyperuricaemia, gout and kidney function in New Zealand Maori men. Br J Rheumatol. 1984 Nov;23(4):276–282. [PubMed]
  • Hochberg MC, Thomas J, Thomas DJ, Mead L, Levine DM, Klag MJ. Racial differences in the incidence of gout. The role of hypertension. Arthritis Rheum. 1995 May;38(5):628–632. [PubMed]
  • Tikly M, Bellingan A, Lincoln D, Russell A. Risk factors for gout: a hospital-based study in urban black South Africans. Rev Rhum Engl Ed. 1998 Apr;65(4):225–231. [PubMed]
  • Lee PD, Giudice LC, Conover CA, Powell DR. Insulin-like growth factor binding protein-1: recent findings and new directions. Proc Soc Exp Biol Med. 1997 Dec;216(3):319–357. [PubMed]
  • Janssen JA, Stolk RP, Pols HA, Grobbee DE, Lamberts SW. Serum free and total insulin-like growth factor-I, insulin-like growth factor binding protein-1 and insulin-like growth factor binding protein-3 Levels in healthy elderly individuals. Relation to self-reported quality of health and disability. Gerontology. 1998;44(5):277–280. [PubMed]
  • Heald AH, Cruickshank JK, Riste LK, Cade JE, Anderson S, Greenhalgh A, Sampayo J, Taylor W, Fraser W, White A, et al. Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations. Diabetologia. 2001 Mar;44(3):333–339. [PubMed]
  • Sandhu Manjinder S, Heald Adrian H, Gibson J Martin, Cruickshank J Kennedy, Dunger David B, Wareham Nicholas J. Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet. 2002 May 18;359(9319):1740–1745. [PubMed]
  • Sandhu Manjinder S, Gibson J Martin, Heald Adrian H, Dunger David B, Wareham Nicholas J. Low circulating IGF-II concentrations predict weight gain and obesity in humans. Diabetes. 2003 Jun;52(6):1403–1408. [PubMed]
  • Cruickshank JK, Heald AH, Anderson S, Cade JE, Sampayo J, Riste LK, Greenhalgh A, Taylor W, Fraser W, White A, et al. Epidemiology of the insulin-like growth factor system in three ethnic groups. Am J Epidemiol. 2001 Sep 15;154(6):504–513. [PubMed]
  • Hopkins KD, Lehmann ED, Jones RL, Holly JM, Cwyfan-Hughes SC, Turay RC, Teale JD, Gosling RG. Ethnicity affects IGFBP-3 and IGF-II in normal healthy young adult subjects. Clin Endocrinol (Oxf) 1996 Sep;45(3):327–331. [PubMed]
  • Heald AH, Cade JE, Cruickshank JK, Anderson S, White A, Gibson JM. The influence of dietary intake on the insulin-like growth factor (IGF) system across three ethnic groups: a population-based study. Public Health Nutr. 2003 Apr;6(2):175–180. [PubMed]
  • Chaturvedi N, Jarrett J, Morrish N, Keen H, Fuller JH. Differences in mortality and morbidity in African Caribbean and European people with non-insulin dependent diabetes mellitus: results of 20 year follow up of a London cohort of a multinational study. BMJ. 1996 Oct 5;313(7061):848–852. [PMC free article] [PubMed]
  • Leggetter Sandra, Chaturvedi Nish, Fuller John H, Edmonds Mike E. Ethnicity and risk of diabetes-related lower extremity amputation: a population-based, case-control study of African Caribbeans and Europeans in the United kingdom. Arch Intern Med. 2002 Jan 14;162(1):73–78. [PubMed]
  • Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS. Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes Care. 1999 Mar;22(3):403–408. [PubMed]
  • Cruickshank JK, Alleyne SA. Black West Indian and matched white diabetics in Britain compared with diabetics in Jamaica: body mass, blood pressure, and vascular disease. Diabetes Care. 1987 Mar-Apr;10(2):170–179. [PubMed]
  • Chaturvedi N, Fuller JH. Ethnic differences in mortality from cardiovascular disease in the UK: do they persist in people with diabetes? J Epidemiol Community Health. 1996 Apr;50(2):137–139. [PMC free article] [PubMed]
  • Balarajan R, Yuen P, Soni Raleigh V. Ethnic differences in general practitioner consultations. BMJ. 1989 Oct 14;299(6705):958–960. [PMC free article] [PubMed]
  • Gillam SJ, Jarman B, White P, Law R. Ethnic differences in consultation rates in urban general practice. BMJ. 1989 Oct 14;299(6705):953–957. [PMC free article] [PubMed]
  • Badger F, Atkin K, Griffiths R. Current comment. (xix). Why don't general practitioners refer their disabled Asian patients to district nurses? Health Trends. 1989 Feb;21(1):31–32. [PubMed]
  • Shaukat N, de Bono DP, Cruickshank JK. Clinical features, risk factors, and referral delay in British patients of Indian and European origin with angina matched for age and extent of coronary atheroma. BMJ. 1993 Sep 18;307(6906):717–718. [PMC free article] [PubMed]
  • Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997 Apr;20(4):537–544. [PubMed]
  • Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001 May 3;344(18):1343–1350. [PubMed]
  • Knowler William C, Barrett-Connor Elizabeth, Fowler Sarah E, Hamman Richard F, Lachin John M, Walker Elizabeth A, Nathan David M. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002 Feb 7;346(6):393–403. [PMC free article] [PubMed]
  • Sartor G, Scherstén B, Carlström S, Melander A, Nordén A, Persson G. Ten-year follow-up of subjects with impaired glucose tolerance: prevention of diabetes by tolbutamide and diet regulation. Diabetes. 1980 Jan;29(1):41–49. [PubMed]
  • Chiasson Jean-Louis, Josse Robert G, Gomis Ramon, Hanefeld Markolf, Karasik Avraham, Laakso Markku. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet. 2002 Jun 15;359(9323):2072–2077. [PubMed]
  • Kaiser T, Sawicki PT. Acarbose for prevention of diabetes, hypertension and cardiovascular events? A critical analysis of the STOP-NIDDM data. Diabetologia. 2004 Mar;47(3):575–580. [PubMed]
  • Buchanan Thomas A, Xiang Anny H, Peters Ruth K, Kjos Siri L, Marroquin Aura, Goico Jose, Ochoa Cesar, Tan Sylvia, Berkowitz Kathleen, Hodis Howard N, et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes. 2002 Sep;51(9):2796–2803. [PubMed]
  • Torgerson Jarl S, Hauptman Jonathan, Boldrin Mark N, Sjöström Lars. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care. 2004 Jan;27(1):155–161. [PubMed]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Group


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...